HPGDS and rosacea: Additionally, null mutations in the GSTM1 and GSTT1 gene loci, which encode glutathione-S-transferase—an enzyme that catalyzes toxic oxidative intermediates—were more frequently observed in rosacea patients compared to the control group [2].